S-E. Dahlén (Stockholm, Sweden), C. Taille (Paris, France)
Late-breaking abstract: Genome-wide association of GLCCI1 with asthma steroid treatment response
K. Tantisira, J. Lasky-Su, M. Harada, A. Murphy, A. Litonjua, B. Himes, C. Lange, R. Lazarus, J. Sylvia, B. Klanderman, Q. Duan, W. Qiu, T. Hirota, F. Martinez, D. Mauger, C. Sorkness, S. Szefler, S. Lazarus, R. Lemanske, S. Peters, J. Lima, Y. Nakamura, M. Tamari, S. Weiss (Boston, Tucson, Hershey, Madison, Denver, San Francisco, Winston-Salem, Jacksonville, United States Of America; Kanagawa, Japan)
|  |
Frequent exacerbators – A distinct phenotype of severe asthma
M. Kupczyk, S. Haque, R. Middelveld, S. E. Dahlen, on Behalf of the BIOAIR Study Group (Stockholm, Sweden)
|  |
Is hypereosinophilic asthma a specific phenotype of asthma?
P. Pradère, Y. Uzunhan, J. Cadranel, A. Bergeron-Lafaurie, D. Israël-Biet, G. Garcia, S. Jouveshomme, M. Varrin, M. Aubier, B. Crestani, C. Taillé (Paris, Bobigny, Clamart, Poissy, Montpellier, France)
| |
Exhaled nitric oxide levels differ between allergic and non-allergic asthma in men, but not in women
M. Imaoka (Fukuoka, Japan)
| |
Does systematic assessment improve healthcare outcomes and healthcare utilisation in patients with severe asthma?
S. Regan, F. Shora, M. Hofmann, A. Menzies-Gow (London, United Kingdom)
| |
Improvement of asthma control by a concomitant therapy with cineole
H. Worth (Fürth, Germany)
| |
Pragmatic controlled trial of azithromycin for asthma in adults
D. Hahn, M. Grasmick, S. Hetzel (Madison, United States Of America)
|  |
Persistent asthma and long-term work disability
P. Kauppi, R. Hakola, T. Leino, A. Ojajärvi, J. Pentti, T. Oksanen, T. Haahtela, M. Kivimäki, J. Vahtera (Helsinki, Turku, Finland)
| |